Evéquoz D, Grouzmann E, Beck-Sickinger A G, Brunner H R, Waeber B
Division d'Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Experientia. 1994 Oct 15;50(10):936-8. doi: 10.1007/BF01923482.
Neuropeptide Y (NPY) increases blood pressure either directly or indirectly by potentiating the effect of various vasoconstrictors. Only one (the Y1-receptor) of two subtypes of receptors (Y1 and Y2) is thought to mediate the vascular smooth muscle contraction. To test this hypothesis we challenged isolated rat mesenteric arteries that had a functional endothelium with (1-36) NPY and with specific Y1-receptor ([Leu31, Pro34] NPY) and Y2-receptor ([Ahx5-24, gamma-Glu2-epsilon-Lys30] NPY) agonists. The Y1-receptor agonist elicited a contractile response similar to that of NPY, whereas the Y2-receptor agonist had no effect on wall tension. We also found that the presence of a functional endothelium has no influence on the contractile response to NPY. From these data we conclude that the direct contractile effect of NPY in the mesenteric artery is mediated by stimulation of Y1-receptors and is not endothelium-dependent.
神经肽Y(NPY)通过增强各种血管收缩剂的作用直接或间接地升高血压。在两种受体亚型(Y1和Y2)中,只有一种(Y1受体)被认为介导血管平滑肌收缩。为了验证这一假设,我们用(1-36)NPY以及特异性Y1受体激动剂([Leu31,Pro34]NPY)和Y2受体激动剂([Ahx5-24,γ-Glu2-ε-Lys30]NPY)刺激具有功能性内皮的离体大鼠肠系膜动脉。Y1受体激动剂引发的收缩反应与NPY相似,而Y2受体激动剂对血管壁张力没有影响。我们还发现功能性内皮的存在对NPY的收缩反应没有影响。从这些数据我们得出结论,NPY在肠系膜动脉中的直接收缩作用是通过刺激Y1受体介导的,且不依赖于内皮。